Remove solutions commercial-delivery value-and-access
article thumbnail

The Power of Personalization Amid the Changing CRO Landscape

Worldwide Clinical Trials

We discovered that nearly 50% of respondents state that large CRO instability has negatively impacted their willingness to partner, citing disruptions to their clinical study project teams, service levels and performance delivery, and project timelines. What Differentiates Mid-Size CROs?

article thumbnail

Tapping into pharma’s growing opportunities in digital health

Pharmaceutical Technology

Pharma, which is already growing its role in delivering hybrid solutions combining therapies with diagnostic and smart solutions and devices, could play a significant role here, providing smart end-to-end solutions and data-related tools that transcend the immediate treatment. Breaking down the opportunities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

thINc’s Value-Based Care Summit

Drug Channels

thINc’s Value-Based Care Summit Accelerating Healthcare’s Shift in the Move from Volume to Value In-Person Event | December 5-6, 2023 in Boston, MA www.thinc350.com/VBCS com/VBCS Use promo code VBCDC to save $100. Register Today.

article thumbnail

Value-Based Care Summit

Drug Channels

Value-Based Care Summit. Accelerating Healthcare’s Shift in the Move from Volume to Value. As healthcare stakeholders continue to prioritize the move to value-based care and aim to provide equitable access to care for all, leaders must develop novel approaches to empower the patient and ensure effective risk-sharing strategies.

article thumbnail

EVERSANA and Intouch Group Join Forces, Adding The Premiere Digital-First Agency Network to the Market Leader in Next Generation Commercialization

Intouch Solutions

Together, the combined companies — with more than 40 global locations; 5,500 employees worldwide; and millions of dollars invested in digital transformation, data and analytics — are poised to deliver full-scale commercialization to pharmaceutical companies globally. CHICAGO and KANSAS CITY, Mo.

article thumbnail

EVERSANA Completes Acquisition of Intouch Group

Intouch Solutions

Adds The Premiere Digital-First Agency Network to the Market Leader in Next G eneration Commercialization. With the added power of Intouch and millions more invested in data, analytics and digital transformation, we are reinventing commercial approaches for the benefit of our clients and their patients.”. CHICAGO and KANSAS CITY, Mo.

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Pricing and approval of advanced therapies Philip Wills, PhD, Chief Commercial Officer, Catalent Cell & Gene Therapy, says that it is already clear that pricing of advanced therapies requires innovative thinking. Pricing and reimbursement continues to be a challenge we address as a field.